Pharmacokinetics of detomidine and its metabolites following intravenous and intramuscular administration in horses

Equine Veterinary Journal

Volumn 41, Issue 4, 2009, Pages 361-365

  Grimsrud, K N ^a   Mama, K R ^b   Thomasy, S M ^a   Stanley, S D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Alpha 2 agonist; Detomidine; Horse; Pharmacokinetics; Sedation

Indexed keywords

EQUIDAE;

DETOMIDINE; HYPNOTIC SEDATIVE AGENT; IMIDAZOLE DERIVATIVE;

ANIMAL; AREA UNDER THE CURVE; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; HALF LIFE TIME; HORSE; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM;

ANIMALS; AREA UNDER CURVE; CROSS-OVER STUDIES; HALF-LIFE; HORSES; HYPNOTICS AND SEDATIVES; IMIDAZOLES; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS;

EID: 67651183710     PISSN: 04251644     EISSN: None     Source Type: Journal    
DOI: 10.2746/042516409X370900     Document Type: Article

References (15)

1. Chambers, J.P., Livingston, A., Waterman, A.E. and Goodship, A.E. (1993) Analgesic effects of detomidine in Thoroughbred horses with chronic tendon injury. Res. vet. Sci. 54, 52-56.
2. Chui, Y.C., Mutlib, A., Esaw, B., Zarate, R. and Young, L.M. (1992) Detection of detomidine and its metabolites in equine plasma and urine by LC/MS/MS. In: Proceedings of the 9th International Conference of Racing Analysts and Veterinarians. pp 85-92.
3. Clark, J.O. and Clark T.P. (1999) Analgesia. Vet. Clin. N. Am.: Equine Pract. 15, 705-723.
4. Dimova, H., Wang, Y., Pommery, S., Moellmann, H. and Hochhaus, G. (2003) SPE/RIA vs. LC/MS for measurement of low levels of budesonide in plasma. Biomed. Chromatogr. 17, 14-20.
5. England, G.C.W. and Clarke, K.W. (1996) Alpha-2 adrenoceptor agonists in the horse: A review. Br. vet. J. 152, 641-657.
6. TM RIA method. J. Chromatography B. 840, 69-74.
7. Gabrielsson, J. and Weiner, D. (2000) Modeling strategies. In: Pharmacokinetic and Pharmacodynamic Analysis: Concepts and Applications, 4th edn., Swedish Pharmaceutical Press, Stockholm. p 460.
8. Oijala, M. and Katila, T. (1998) Detomidine (Domosedan) in foals: sedative and analgesic effects. Equine vet. J. 20, 327-330.
9. Salonen, J.S. (1986) Pharmacokinetics of detomidine. Acta vet. Scand. 82, 59-66.
10. Salonen, J.S., Vaha-Vahe, T., Vainio, O. and Vakkuri, O. (1989) Single-dose pharmacokinetics of detomidine in the horse and cow. J. vet. Pharmacol. Therap. 12, 65-72.
11. Salonen, J.S., Vuorilehto, L., Eloranta, M. and Karjalainen, A. (1988) Metabolism of detomidine in the rat II. Characterization of metabolites in urine. Eur. J. Drug Met. Pharmacokinetics 13, 59-65.
12. Sarazan, R.D., Starke, W.A., Krause, G.F. and Garner, H.E. (1989) Cardiovascular effects of detomidine, a new α2-adrenoceptor agonist, in the conscious pony. J. vet. Pharmacol. Therap. 12, 378-388.
13. Stanley, S.D., Yang, J-M., Wood, T.W., Salonen, J.S., Watt, D., Tai, H-H. and Tobin, T. (1992) Detomidine clearance in the horse as determined by ELISA. In: Proceedings of the 9th International Conference of Racing Analysts and Veterinarians. pp 193-197.
14. Wagner, A.E., Muir, W.W. and Hinchcliff, K.W. (1991) Cardiovascular effects of xylazine and detomidine in horses. Am. J. vet. Res. 52, 651-657.
15. Wood, T., Tai, C.L., Taylor, D.G., Woods, W.E., Wang, C-J., Houtz, P.K., Tai, H-H., Weckman, T.J., Yang, J-M., Sturma, L., Chang, S-L., Goodman, J.P., Stanley, S.D., Blake, J.W., Watt, D.S. and Tobin, T. (1989) Immunoassay detection of drugs in racing horses IX. Detection of detomidine in equine blood and urine by radioimmunoassay. Res. Commun. Chem. Pathol. Pharmacol. 63, 263-279.